{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:01:20Z","timestamp":1791910880690,"version":"4.3.4"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Prostate cancer (PCa) is one of the most common malignancies in men, but patient outcomes are varied depending on extent of disease. Radical, whole-gland therapies, such as prostatectomy or radiotherapy, are definitive treatments for PCa, but they are associated with significant morbidity, including erectile dysfunction and urinary incontinence. Focal therapies for PCa, whereby the part of gland harboring disease is selectively treated, spares the normal surrounding structures, and minimizes the morbidity associated with whole gland treatment. The use of magnetic resonance imaging (MRI) guidance provides advantages over ultrasound guidance, such as better localization and targeting of clinically significant PCa (csPCa), as well as MRI thermometry which optimizes tissue ablation temperatures. This review will discuss two MRI-guided high-intensity focused ultrasound (HIFU) techniques \u2013 transrectal MR-guided focused ultrasound (MRgFUS) and TULSA (transurethral ultrasound ablation) ablation for localized PCa. Overall, recent major trials for MRgFUS and TULSA have shown promising oncological and functional results in the treatment of low- to intermediate-risk PCa. Recent Phase II MRgFUS trials have shown better oncologic outcomes than the published results for focal ultrasound guided HIFU and may justify the additional costs associated with MRI guidance. While initial studies on TULSA have focused on subtotal gland ablation, recent trials assessing oncological outcomes for focal treatment of angular sectors have shown promise.<\/jats:p>","DOI":"10.3389\/fonc.2022.1069518","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T21:05:21Z","timestamp":1672866321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Magnetic resonance imaging-guided ultrasound ablation for prostate cancer \u2013 A contemporary review of performance"],"prefix":"10.3389","volume":"12","author":[{"given":"Mostafa","family":"Alabousi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeet","family":"Ghai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4329\/WJR.V4.I6.247","article-title":"Ultrasound- and MR-guided focused ultrasound surgery for prostate cancer","volume":"4","author":"Zini","year":"2012","journal-title":"World J Radiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/S11934-020-01020-Y","article-title":"MR-guided high-intensity directional ultrasound ablation of prostate cancer","volume":"22","author":"Galgano","year":"2021","journal-title":"Curr Urol Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: Definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002854","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00251-0","article-title":"MRI-Guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study","volume":"23","author":"Ehdaie","year":"2022","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2019.20675","article-title":"Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer","volume":"323","author":"Hoffman","year":"2020","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.5489\/CUAJ.2806","article-title":"Active surveillance for the management of localized prostate cancer: Guideline recommendations","volume":"9","author":"Morash","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/J.JURO.2016.06.100","article-title":"Evaluation of focal ablation of magnetic resonance imaging defined prostate cancer using magnetic resonance imaging controlled transurethral ultrasound therapy with prostatectomy as the reference standard","volume":"197","author":"Ramsay","year":"2017","journal-title":"J Urol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1148\/RADIOL.2021202717","article-title":"MRI-Guided focused ultrasound ablation for localized intermediate-risk prostate cancer: Early results of a phase II trial","volume":"298","author":"Ghai","year":"2021","journal-title":"Radiology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/J.EURURO.2015.01.030","article-title":"Focal ablation targeted to the index lesion in multifocal localised prostate cancer: a prospective development study","volume":"68","author":"Ahmed","year":"2015","journal-title":"Eur Urol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.22.28413","article-title":"Beyond the AJR: MRI-guided focused ultrasound focal therapy for intermediate-risk prostate cancer","author":"Ghai","year":"2022","journal-title":"AJR Am J Roentgenol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.13285","article-title":"Characteristics of detected and missed prostate cancer foci on 3-T multiparametric MRI using an endorectal coil correlated with whole-mount thin-section histopathology","volume":"205","author":"Tan","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/J.JURO.2016.07.084","article-title":"Magnetic resonance imaging underestimation of prostate cancer geometry: Use of patient specific molds to correlate images with whole mount pathology","volume":"197","author":"Priester","year":"2017","journal-title":"J Urol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/J.JURO.2015.02.080","article-title":"Image guided focal therapy for magnetic resonance imaging visible prostate cancer: Defining a 3-dimensional treatment margin based on magnetic resonance imaging histology Co-registration analysis","volume":"194","author":"le Nobin","year":"2015","journal-title":"J Urol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1159\/000474679","article-title":"High-intensity focused ultrasound experimentation on human benign prostatic hypertrophy","author":"Gelet","year":"1993","journal-title":"Eur Urol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/S00270-013-0592-4","article-title":"MR-guided high-intensity focused ultrasound: current status of an emerging technology","volume":"36","author":"Napoli","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/J.EURURO.2018.06.006","article-title":"A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer","volume":"74","author":"Guillaumier","year":"2018","journal-title":"Eur Urol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/J.EURURO.2022.01.005","article-title":"Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: A multi-institute 15-year experience","volume":"81","author":"Reddy","year":"2022","journal-title":"Eur Urol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/J.EURURO.2015.06.018","article-title":"Focal high-intensity focused ultrasound targeted hemiablation for unilateral prostate cancer: A prospective evaluation of oncologic and functional outcomes","volume":"69","author":"Feijoo","year":"2016","journal-title":"Eur Urol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/BJU.14710","article-title":"Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer","volume":"124","author":"Stabile","year":"2019","journal-title":"BJU Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA1801993","article-title":"MRI-Targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1146\/ANNUREV.MED.60.041707.170303","article-title":"MRI-Guided focused ultrasound surgery","volume":"60","author":"Jolesz","year":"2009","journal-title":"Annu Rev Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1148\/RG.25SI055501","article-title":"Microwave ablation: principles and applications","author":"Simon","year":"2005","journal-title":"Radiographics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2020.1755258","article-title":"High-intensity focused ultrasound for prostate cancer","volume":"17","author":"Napoli","year":"2020","journal-title":"Expert Rev Med Devices"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/S00345-020-03297-7","article-title":"Focal HIFU therapy for anterior compared to posterior prostate cancer lesions","volume":"39","author":"Huber","year":"2021","journal-title":"World J Urol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2014.17942","article-title":"Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer","volume":"313","author":"Siddiqui","year":"2015","journal-title":"JAMA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.13098","article-title":"Real-time MRI-guided focused ultrasound for focal therapy of locally confined low-risk prostate cancer: Feasibility and preliminary outcomes","volume":"205","author":"Ghai","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/S00330-018-5409-Z","article-title":"Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial","volume":"28","author":"Ghai","year":"2018","journal-title":"Eur Radiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(96)00233-6","article-title":"Mechanism of healing of the human prostatic urethra following thermal injury","volume":"48","author":"Orihuela","year":"1996","journal-title":"Urology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/J.EURURO.2012.11.002","article-title":"Real-time magnetic resonance-guided high-intensity focused ultrasound focal therapy for localised prostate cancer: preliminary experience","volume":"63","author":"Napoli","year":"2013","journal-title":"Eur Urol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1148\/RADIOL.2017161650","article-title":"Focal therapy for prostate cancer with in-bore MR-guided focused ultrasound: Two-year follow-up of a phase I trial-complications and functional outcomes","volume":"285","author":"Tay","year":"2017","journal-title":"Radiology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/S00330-022-08822-3","article-title":"Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy","volume":"32","author":"Deniffel","year":"2022","journal-title":"Eur Radiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70121-3","article-title":"Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study","volume":"13","author":"Ahmed","year":"2012","journal-title":"Lancet Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1148\/RADIOL.12112263","article-title":"MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans","volume":"265","author":"Chopra","year":"2012","journal-title":"Radiology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/J.EURURO.2015.12.029","article-title":"Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: A prospective phase 1 clinical trial","volume":"70","author":"Chin","year":"2016","journal-title":"Eur Urol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/21681805.2019.1660707","article-title":"Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer","volume":"53","author":"Anttinen","year":"2019","journal-title":"Scand J Urol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/0284185120976931","article-title":"Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer","volume":"62","author":"M\u00e4kel\u00e4","year":"2021","journal-title":"Acta Radiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/BJU.15268","article-title":"Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localised prostate cancer: 3-year outcomes of a prospective phase I study","volume":"127","author":"Nair","year":"2021","journal-title":"BJU Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001362","article-title":"Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate cancer","volume":"205","author":"Klotz","year":"2021","journal-title":"J Urol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/J.EUROS.2020.10.007","article-title":"Salvage magnetic resonance imaging-guided transurethral ultrasound ablation for localized radiorecurrent prostate cancer: 12-month functional and oncological results","volume":"22","author":"Anttinen","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/02841851221108292","article-title":"Safety and efficacy of MRI-guided transurethral ultrasound ablation for radiorecurrent prostate cancer in the presence of gold fiducial markers","author":"M\u00e4kel\u00e4","year":"2022","journal-title":"Acta Radiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/BJU.15523","article-title":"Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12-month clinical outcomes of a phase I study","volume":"129","author":"Viitala","year":"2022","journal-title":"BJU Int"},{"key":"B44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/END.2020.0511","article-title":"Relief of lower urinary tract symptoms after MRI-guided transurethral ultrasound ablation for localized prostate cancer: Subgroup analyses in patients with concurrent cancer and benign prostatic hyperplasia","volume":"35","author":"Elterman","year":"2021","journal-title":"J Endourol"},{"key":"B45","unstructured":"Prostate cancer - TULSA"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1259\/BJR.20210414","article-title":"Role of multiparametric MRI in long-term surveillance following focal laser ablation of prostate cancer","volume":"95","author":"Paxton","year":"2022","journal-title":"Br J Radiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"30.e9","DOI":"10.1016\/J.UROLONC.2016.07.015","article-title":"Prostate-specific antigen vs. Magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer","volume":"35","author":"Dickinson","year":"2017","journal-title":"Urol Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1069518\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T21:05:24Z","timestamp":1672866324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1069518\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":47,"alternative-id":["10.3389\/fonc.2022.1069518"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.1069518","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1069518"}}